Advances in the application of PD-1/PD-L1 immunotherapy for prostate cancer: a review
Prostate cancer (PCa), the most prevalent malignancy among male genitourinary cancers, is distinguished by its immunologically ”cold” phenotype with persistently high incidence and mortality. Radical prostatectomy and radiotherapy represent the current…